Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 759 publications
Reply: Biochemical Remission and Residual Cardiac Abnormalities in AL Amyloidosis.
Journal: JACC. CardioOncology
Published: June 28, 2026
Bioepidemiology of cardiac amyloidosis.
Journal: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Published: June 12, 2026
Prevalence and Burden of Cardiac Amyloidosis in a Population-Based Autopsy Cohort.
Journal: Circulation
Published: June 08, 2026
Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial.
Journal: Journal of the peripheral nervous system : JPNS
Published: June 05, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.
Journal: American journal of hematology
Published: May 30, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 14, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.
Journal: American journal of hematology
Published: March 31, 2026
Self-Reported Geriatric Impairments and Treatment Toxicity in Older Patients with Multiple Myeloma-A Single Center Prospective Study.
Journal: Blood advances
Published: March 31, 2026
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia.
Journal: American journal of hematology
Published: March 31, 2026
Last Updated: 09/26/2026